Literature DB >> 2835835

Alteration in immune response of mice with dual infection of Toxocara canis and Japanese encephalitis virus.

A K Gupta1, K M Pavri.   

Abstract

Concurrent dual infections of mice with Toxocara canis and Japanese encephalitis virus (JEV) showed a distinct synergistic effect of the parasite on sublethal JEV infection. Dose-dependent effects were evident in the mice infected dually and with T. canis alone; leucocytosis with suppression of eosinophilia in the peripheral blood and reduction in migration inhibition factor produced by spleen cells in response to T. canis and JEV antigens were recorded, particularly in the former group. These changes were accompanied by reductions in both antibody response to sheep erythrocytes and T cell numbers in the spleen. No appreciable changes were recorded in the mice infected with JEV alone. Thus, the T cell immuno-suppression induced by T. canis might have triggered the viral encephalitis caused by JEV in the dual infections.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2835835     DOI: 10.1016/0035-9203(87)90046-0

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  4 in total

1.  Coexistent neurocysticercosis and Japanese B encephalitis: MR imaging correlation.

Authors:  P Singh; N Kalra; R K Ratho; S Shankar; N Khandelwal; S Suri
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

2.  Coinfection of Japanese encephalitis with neurocysticercosis: an imaging study.

Authors:  S K Handique; R R Das; B Saharia; P Das; R Buragohain; P Saikia
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-10       Impact factor: 3.825

3.  Toxocara canis: molecular basis of immune recognition and evasion.

Authors:  Rick M Maizels
Journal:  Vet Parasitol       Date:  2012-12-20       Impact factor: 2.738

Review 4.  Pathogenesis of flavivirus encephalitis.

Authors:  Thomas J Chambers; Michael S Diamond
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.